These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 501097)

  • 1. Cytotoxic properties of the eosinophil major basic protein.
    Gleich GJ; Frigas E; Loegering DA; Wassom DL; Steinmuller D
    J Immunol; 1979 Dec; 123(6):2925-7. PubMed ID: 501097
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxic properties of eosinophil granule major basic protein for tumor cells.
    Kubo H; Loegering DA; Adolphson CR; Gleich GJ
    Int Arch Allergy Immunol; 1999; 118(2-4):426-8. PubMed ID: 10224465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic vasculitis associated with eosinophilia and marked degranulation of tissue eosinophils.
    Fischer TJ; Daugherty C; Gushurst C; Kephart GM; Gleich GJ
    Pediatrics; 1988 Jul; 82(1):69-75. PubMed ID: 3380602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron microscopic localization of silver binding proteins in the cytoplasmic granules of guinea pig eosinophil.
    Gancevici G; Petrovici A
    Roum Arch Microbiol Immunol; 1993; 52(2):81-8. PubMed ID: 8186458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA-induced eosinophil degranulation.
    Abu-Ghazaleh RI; Fujisawa T; Mestecky J; Kyle RA; Gleich GJ
    J Immunol; 1989 Apr; 142(7):2393-400. PubMed ID: 2926137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein.
    Torpier G; Colombel JF; Mathieu-Chandelier C; Capron M; Dessaint JP; Cortot A; Paris JC; Capron A
    Clin Exp Immunol; 1988 Dec; 74(3):404-8. PubMed ID: 3233790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo: cytotoxic potential in Crohn's disease.
    Dvorak AM
    J Immunol; 1980 Jul; 125(1):460-2. PubMed ID: 6155407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium.
    Frigas E; Loegering DA; Gleich GJ
    Lab Invest; 1980 Jan; 42(1):35-43. PubMed ID: 7351830
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein.
    Lehrer RI; Szklarek D; Barton A; Ganz T; Hamann KJ; Gleich GJ
    J Immunol; 1989 Jun; 142(12):4428-34. PubMed ID: 2656865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function?
    Lee JJ; Lee NA
    Clin Exp Allergy; 2005 Aug; 35(8):986-94. PubMed ID: 16120079
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils.
    Gleich GJ; Loegering DA; Mann KG; Maldonado JE
    J Clin Invest; 1976 Mar; 57(3):633-40. PubMed ID: 942977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of an eosinophil chemotactic lymphokine as a natural mediator for eosinophil chemotaxis from concanavalin A-induced skin reaction sites in guinea-pigs.
    Hirashima M; Tashiro K; Sakata K; Hirashima M
    Clin Exp Immunol; 1984 Jul; 57(1):211-9. PubMed ID: 6378462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priming and induction of eosinophil trafficking in guinea-pig cutaneous inflammation by tumour necrosis factor alpha.
    Macari DM; Teixeira MM; Ansari T; Jeffery PK; Hellewell PG
    Br J Pharmacol; 1998 Nov; 125(6):1228-35. PubMed ID: 9863651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil degranulation. An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis.
    Ackerman SJ; Kephart GM; Francis H; Awadzi K; Gleich GJ; Ottesen EA
    J Immunol; 1990 May; 144(10):3961-9. PubMed ID: 2332637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome.
    Simon HU; Plötz S; Simon D; Seitzer U; Braathen LR; Menz G; Straumann A; Dummer R; Levi-Schaffer F
    Eur J Immunol; 2003 Apr; 33(4):834-9. PubMed ID: 12672048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil major basic protein: first identified natural heparanase-inhibiting protein.
    Temkin V; Aingorn H; Puxeddu I; Goldshmidt O; Zcharia E; Gleich GJ; Vlodavsky I; Levi-Schaffer F
    J Allergy Clin Immunol; 2004 Apr; 113(4):703-9. PubMed ID: 15100677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granular proteins of eosinophils.
    Monteseirín J; Prados M; Bonilla I; Llamas E; Delgado J; Sánchez-Monteseirín H; Chaparro A; Conde J
    Allergol Immunopathol (Madr); 1996; 24(5):219-25. PubMed ID: 8985478
    [No Abstract]   [Full Text] [Related]  

  • 18. The functions of eosinophils.
    Gleich GJ
    Ann Inst Pasteur Immunol; 1986; 137D(1):136-41. PubMed ID: 3530112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil-induced chronic active hepatitis in the idiopathic hypereosinophilic syndrome.
    Foong A; Scholes JV; Gleich GJ; Kephart GM; Holt PR
    Hepatology; 1991 Jun; 13(6):1090-4. PubMed ID: 2050327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effector functions of the polynuclear eosinophil].
    Capron M; Prin L; Tonnel AB; Capron A
    Poumon Coeur; 1983; 39(2):65-73. PubMed ID: 6224142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.